T-lymphocyte recovery and function after cord blood transplantation
Author:
- 3 December 2010
- journal article
- research article
- Published by Springer Nature in Immunologic Research
- Vol. 49 (1-3) , 56-69
Abstract
The Szabolcs laboratory is focused on understanding the biology of donor-derived cellular immunity in recipients of allogeneic hematopoietic cell transplantation that can be translated into new immunotherapy strategies. To this end, we are focused on developing novel laboratory approaches to analyze and augment immune recovery for high risk patient cohorts without increasing graft-versus-host disease. Much of our work has focused on unrelated cord blood transplantation as the dominant clinical scenario and laboratory model. Our overarching goal is to minimize transplant-related mortality and morbidity and render HLA-mismatched unrelated cord blood transplant, a widely accepted safe cellular therapy. Donor leukocyte infusions in the allogeneic hematopoietic transplant setting can provide a clinically relevant boost of immunity to reduce opportunistic infections and to increase graft-versus-leukemia activity. Our laboratory has a major focus toward ex vivo expansion of cord blood T cells with anti-apoptotic cytokines and CD3/CD28 co-stimulatory beads. Expanded lymphocytes lack alloreactivity against recipient and other allogeneic cells indicating a favorable safety profile from graft-versus-host disease. Nevertheless, expanded T cells can be primed subsequently against lymphoid and myeloid leukemia cells to generate tumor-specific cytotoxic T cells. These findings offer a major step in fulfilling critical biological requirements to quickly generate a cellular product ex vivo, using a negligible fraction of a cord blood graft that provides a flexible adoptive immunotherapy platform for both children and adults.Keywords
This publication has 66 references indexed in Scilit:
- Interleukin-7 Permits Th1/Tc1 Maturation and PromotesEx vivoExpansion of Cord Blood T Cells: A Critical Step toward Adoptive Immunotherapy after Cord Blood TransplantationCancer Research, 2010
- Cord blood transplantation: state of the artHaematologica, 2009
- Ex Vivo Expansion and Th1/Tc1 Maturation of Umbilical Cord Blood T Cells by CD3/CD28 CostimulationTransplantation and Cellular Therapy, 2008
- Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewingBlood, 2007
- Immune reconstitution after unrelated cord blood transplantationCytotherapy, 2007
- Antigen-Specific T-Lymphocyte Function After Cord Blood TransplantationTransplantation and Cellular Therapy, 2006
- In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytesBlood, 2006
- Cord Blood Immunology and Stem Cell TransplantationHuman Immunology, 2005
- The Immunological Pregnancy Protective Effect of Progesterone Is Manifested via Controlling Cytokine ProductionAmerican Journal of Reproductive Immunology, 1996
- Hematopoietic Reconstitution in a Patient with Fanconi's Anemia by Means of Umbilical-Cord Blood from an HLA-Identical SiblingNew England Journal of Medicine, 1989